TG Therapeutics | TGTX - 市值



金融业
股票价格
USD
资产
USD 1.06B
现金及等价物
USD 199.51M
销售成本
USD 38.14M
流动资产
USD 630.76M
流动负债
USD 153.76M
债务
USD 245.34M
EBIT
USD 50.49M
EBITDA
USD 32.69M
员工
338
EPS每股收益
USD 0.14
股本和储备
USD 648.02M
销售毛利
USD 154.43M
债务利息支出
USD 6.53M
贷款资金
USD 245.65M
市值
USD 5.46B
净收入
USD 23.04M
营业费用
USD 142.08M
营业利润
USD 50.49M
普通股股本
USD 155.21M
PE价格收益
10.76
税前利润
USD 45.09M
销售收入
USD 192.57M
销售和管理费用
USD 50.73M
股票
USD 125.59M
贸易债权人
USD 61.64M
应收帐款人
USD 265.38M


市值 更改 日
AbbVie USD 403.83B 5.2B 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
Amgen USD 176.25B 24.32B 2025-12
Ardelyx USD 1.42B 89M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
Biogen USD 25.82B 5.28B 2025-12
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Curis USD 3M 10M 2026-04
Gilead Sciences USD 166.62B 14.34B 2026-04
Infinity Pharmaceuticals USD 0 0 2026-04
J&J USD 561.65B 17.5B 2026-04
Karyopharm Therapeutics USD 652M 517M 2026-04
Novartis USD 234.78B 72.98B 2026-04
Novavax USD 1.09B 316M 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
TG Therapeutics USD 4.73B 1B 2025-12
Verastem USD 134M 462M 2026-04
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12